Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Active not recruiting 2 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colonic Neoplasms 3 Adenoma 2 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Soft Tissue Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myocardial Infarction 1 Multiple Myeloma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematuria 1 Hematologic Diseases 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adenomatous Polyps 1 Adenocarcinoma of Lung 1 Acute Coronary Syndrome 1

Interventions

Docetaxel 56 Prednisone 36 enzalutamide 25 Leuprolide 24 Magnetic Resonance Spectroscopy 19 Abiraterone Acetate 19 bicalutamide 17 Radiotherapy 15 Goserelin 15 abiraterone 12 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 11 olaparib 9 Androgen Antagonists 9 gallium 68 PSMA-11 8 cabazitaxel 8 Radiotherapy, Intensity-Modulated 8 Metformin 8 Ketoconazole 8 Gonadotropin-Releasing Hormone 8 Cyclophosphamide 8 apalutamide 7 Doxorubicin 7 luprolide acetate gel depot 6 cabozantinib 6 Radiosurgery 6 Estramustine 6 Dexamethasone 6 Calcitriol 6 Biopsy 6 pembrolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms × Aspirin × Clear all

NCT02420652 2023-02-08

PRIMA

Rutgers, The State University of New Jersey

Phase 2 Terminated

27 enrolled 6 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡